Host: |
Rabbit |
Applications: |
IHC/ELISA |
Reactivity: |
Human |
Note: |
FOR SCIENTIFIC EDUCATIONAL RESEARCH USE ONLY (RUO). MUST NOT BE USED IN DIAGNOSTIC OR OTHER MEDICAL APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-Horma Domain-Containing Protein 2 is suitable for use in Immunohistochemistry and ELISA research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.05% NaN3 and 40% Glycerol, pH7.4 |
Purification: |
Antigen affinity purification |
Concentration: |
0.96 mg/mL |
Dilution Range: |
IHC 1:50-1:100 |
Storage Instruction: |
Store at-20°C for long term, and avoid freeze-thaw cycles. |
Tissue Specificity | Highly expressed in testis (at protein level). Expressed in lung adenocarcinoma and squamous cell carcinoma (at protein level). Expressed at lower levels in the liver, brain and kidney. |
Post Translational Modifications | Phosphorylated in a SPO11-dependent manner. |
Function | Essential for synapsis surveillance during meiotic prophase via the recruitment of ATR activity. Plays a key role in the male mid-pachytene checkpoint and the female meiotic prophase checkpoint: required for efficient build-up of ATR activity on unsynapsed chromosome regions, a process believed to form the basis of meiotic silencing of unsynapsed chromatin (MSUC) and meiotic prophase quality control in both sexes. Required for the DNA double-strand break-independent, BRCA1-dependent activation of ATR on the sex chromosomes that is essential for normal sex body formation. |
Protein Name | Horma Domain-Containing Protein 2 |
Cellular Localisation | NucleusChromosomePreferentially Localizes To Unsynapsed Or Desynapsed Chromosomal Regions During The Male And Female Prophase I Stage Of MeiosisTrip13 Is Required For Depletion From Synapsed Chromosomes |
Alternative Antibody Names | Anti-Horma Domain-Containing Protein 2 antibodyAnti-HORMAD2 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance